Minerva Neurosciences | NERV - EPS Earnings Per Share


Minerva Neurosciences reported $-0.56 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Adma Biologics USD 0.2 0.05 Dec/2025
ALKERMES USD 0.29 0.2 Dec/2025
Alterity Therapeutics Limited AUD 0 0 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Cipla INR 15.2 1.52 Dec/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD 0.59 0.67 Dec/2025
CSL USD 5.07 3 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Grifols EUR 0.29 0.11 Mar/2026
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Merck USD 2.04 0.54 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Takeda JPY 65.74 73.57 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024